Home/ Supplements/ Omega 3/ CitraNatal Essence DHA Soft Gel

CitraNatal Essence DHA Soft Gel

product on market Softgel Capsule Mission Pharmacal CitraNatal Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Docosahexaenoic Acid (DHA) is an omega-3 fatty acid supported by strong evidence for promoting fetal brain and retinal development during pregnancy. Research indicates it plays a critical role in neurological function and cognitive growth. The ingredient profile maintains a high safety rating for prenatal use.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for CitraNatal Essence DHA Soft Gel
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
Other Combinations
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Gelatin Glycerin high Oleic Sunflower Oil Contains 2% or less
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Dosage and administration: One tablet and one soft gel daily or as directed by a physician.

Warnings & Precautions

Contraindications: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Warning: Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.

Caution: Exercise caution to ensure the prescribed dosage of DHA does not exceed 1 gram (1000 mg) per day.

To report a serious adverse event or obtain product information, call (800)298-1087

Please consult your health care provider with any dietary concerns.

Formulation Notes

When good nutrition is essential

Quality ingredients, true comfort: 300 mg DHA

Description: CitraNatal Essence is a prescription prenatal/postnatal multi-vitamin/mineral tablet with Ferr-Ease, a dual-iron delivery comprising both a quick release and slow release iron, and a soft gel of DHA, an essential fatty acid.

The prenatal vitamin is a white, coated, oval multi-vitamin/mineral tablet. The tablet is debossed "0864" on one side and is blank on the other. The essential fatty acid DHA soft gel is oblong, transparent, and caramel colored.

Indications: CitraNatal Essence is a multi-vitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.

How Supplied: Six child-resistant blister packs of 5 tablets and 5 soft gels each

Additional Information

NDC 0178-0864-30 Rx Only

Please see side of carton for other important ingredients. In child-resistant packaging

Storage: Store at 20 degrees C to 25 degrees C (68 degrees F to 77 degrees F), excursions permitted between 15 degrees C and 30 degrees C (between 59 degrees F and 86 degrees F). Brief exposure to temperatures up to 40 degrees C (104 degrees F) may be tolerated provided the mean kinetic temperature does not exceed 25 degrees C (77 degrees F); however, such exposure should be minimized.

Metadata

Product Details

UPC / SKU3 01780 86430 2
DSLD Entry Date2020-08-23
Product TypeOther Combinations
FormSoftgel Capsule
DSLD ID232435
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.